Robert Discordia, PhD
Robert Discordia, PhD
Robert Discordia, PhD
Co-Founder, President &
Chief Executive Officer
Peter Hendricks, PhD
Robert Discordia, PhD
Robert Discordia, PhD
Co-Founder & Director
Clinical Psychology
Bruce Blough, PhD
Robert Discordia, PhD
Kevin Murnane, PhD
Co-Founder & Director
Medicinal Chemistry
Kevin Murnane, PhD
Kevin Murnane, PhD
Kevin Murnane, PhD
Co-Founder & Director Neuropharmacology & Neurotoxicology
Amy Reichelt, PhD
Kevin Murnane, PhD
Amy Reichelt, PhD
Chief Scientific Advisor
Drew Mouton,
Kevin Murnane, PhD
Amy Reichelt, PhD
Chief Business Officer
Scientific Advisory board
Richard Shelton, MD
Bruce D. Car, DVM, PhD, DACVP
Bruce D. Car, DVM, PhD, DACVP
Sr. Medical Advisor
Professor of Psychiatry & Behavioral Neurobiology at the University of Alabama, Birmingham; Vice-Chair for Research, Head of Mood Disorders Research Center
Bruce D. Car, DVM, PhD, DACVP
Bruce D. Car, DVM, PhD, DACVP
Bruce D. Car, DVM, PhD, DACVP
Sr. Scientific Advisor
Chief Scientific Officer
Biohaven Pharmaceuticals
John J. Renger, PhD
Bruce D. Car, DVM, PhD, DACVP
Andrew P. Riley, PhD
Sr. Scientific Advisor
Principal Consultant
Neurtuitive, LLC
Former Chief Scientific Officer
Cerevel Therapeutics
Andrew P. Riley, PhD
Andrew P. Riley, PhD
Andrew P. Riley, PhD
Sr. Scientific Advisor
Associate Professor
Department of Pharmaceutical Sciences
University of Illinois Chicago
Pamela P. Perry, MS
Andrew P. Riley, PhD
Pamela P. Perry, MS
Sr. Clinical Advisor
Former SVP Clinical Operations, Data Management & Global Quality
Cerevel Therapeutics
Principal Consultant,
P3 Pharma Consulting, LLC
Neal Naito, MD, MPH
Andrew P. Riley, PhD
Pamela P. Perry, MS
Sr. Medical Advisor
Co-Founder & Chief Executive & Chief Medical Officer MVK Pharmaceuticals
Captain and Director of Public Health, United States Navy Medical Corps (retired)